{"id":139514,"date":"2024-11-25T12:52:58","date_gmt":"2024-11-25T07:22:58","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=139514"},"modified":"2024-11-25T12:53:01","modified_gmt":"2024-11-25T07:23:01","slug":"pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/","title":{"rendered":"Pharma stock jumps after it partners with global pharma company for product development"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-914992585\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>This Midcap Pharma stock which is engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services is up by 2.6 percent after the company collaborated with a global pharma major for the development and commercialization of products.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-34779458\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price Action&nbsp;<\/strong><\/h2><p>With a market capitalization of Rs. 71,914.86 Crores, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/AUROPHARMA\" target=\"_blank\" rel=\"noreferrer noopener\">Aurobindo Pharma Limited<\/a><\/strong> were up by 2.6 percent in the day\u2019s trade and touched a day\u2019s high of Rs. 1,255.90 per equity share, from its previous day\u2019s close price of Rs. 1,223.65. The stock has delivered a return of 22 percent in the past year which has outperformed the nifty index in the same period. The stock has reiterated from the day\u2019s high and currently trading at Rs. 1,243.9 apiece which is 1.65 percent higher.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened&nbsp;<\/strong><\/h2><p>The company announced a collaboration and license agreement with a global pharma major for product development and commercialization for an upfront agreement of $25 million on the agreement&#8217;s effective date.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>The terms and conditions with rationale behind the collaboration<\/strong><\/h2><p>Aurobindo Pharma USA Inc., the wholly owned subsidiary of Aurobindo Pharma has entered into a collaboration and licensing agreement with a global pharmaceutical company for the development of specific products in the respiratory therapeutic area.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-757952956\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>This partnership is expected to last between three to five years, during which both parties will co-exclusively commercialize the products. Once developed, the products will be manufactured at the partner&#8217;s facility and will be marketed jointly. Aurobindo retains the option for technology transfer in the future. The financial terms of the agreement are confidential, but both companies will share development costs equally which is capped at $90 million for Aurobindo.<\/p><p>The collaboration aims to share the product development risks and costs, shorten the development timeline, and strengthen and diversify the existing product portfolio.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company&nbsp;<\/strong><\/h2><p>Aurobindo Pharma Limited, founded in 1986, is a major Indian pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals and active pharmaceutical ingredients.&nbsp;<\/p><p>They operate across various therapeutic segments which include antibiotics, cardiovascular, anti-retrovirals, and central nervous system products. Aurobindo&#8217;s business model focuses on vertical integration, with extensive R&amp;D capabilities and a robust global presence in over 150 countries. They focus on cost-effective drug development, using India&#8217;s competitive advantages to provide affordable healthcare solutions.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials &amp; Ratios&nbsp;<\/strong><\/h2><p>Its Revenue from operations rose by 8 percent year on year from Rs. 7,219 Crores in Q2FY24 to Rs. 7,796 Crores in Q2FY25, accompanied by profits of Rs. 752 Crores to Rs. 817 Crores.&nbsp;<\/p><p>In terms of Return ratios, it has reported a return on equity (ROE) of 11.18 percent and a return on capital employed (ROCE) of 13.51 percent. It has reported a debt-to-equity ratio of 0.21.<\/p><div class=\"trade-content-10\" id=\"trade-4181451918\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Shareholding Pattern<\/strong><\/h2><p>As of September 2024, the shareholding pattern with promoters stake holding a major share of 51.82 percent in Aurobindo Pharma, Foreign Institutional Investors (FII) holding around 16.59 percent,&nbsp; Domestic Institutional investors (DII) standing at 25.14 percent, and public holdings standing at 6.45 percent.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Santhosh S&nbsp;<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading has-medium-font-size\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-1210015786\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>This Midcap Pharma stock which is engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services is up by 2.6 percent after the company collaborated with a global pharma major for the development and commercialization of products. Price Action&nbsp; With a market capitalization of Rs. 71,914.86 Crores, the shares of Aurobindo [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[1734,9217,24885,6616,15654,948,936,3157,12636],"class_list":["post-139514","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-aurobindo-pharma","tag-aurobindo-pharma-latest-news","tag-aurobindo-pharma-news","tag-pharma-stock","tag-pharma-stock-news","tag-stock-market","tag-stock-market-news","tag-stock-to-watch","tag-why-is-aurobindo-pharma-share-going-up"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps after it partners with global pharma company for product development - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"This Midcap Pharma stock which is engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services is up by 2.6 percent after the company collaborated with a global pharma major for the development and commercialization of products.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps after it partners with global pharma company for product development\" \/>\n<meta property=\"og:description\" content=\"This Midcap Pharma stock which is engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services is up by 2.6 percent after the company collaborated with a global pharma major for the development and commercialization of products.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-25T07:22:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-25T07:23:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/\",\"name\":\"Pharma stock jumps after it partners with global pharma company for product development - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-11-25T07:22:58+00:00\",\"dateModified\":\"2024-11-25T07:23:01+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"This Midcap Pharma stock which is engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services is up by 2.6 percent after the company collaborated with a global pharma major for the development and commercialization of products.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps after it partners with global pharma company for product development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps after it partners with global pharma company for product development - Trade Brains Features","description":"This Midcap Pharma stock which is engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services is up by 2.6 percent after the company collaborated with a global pharma major for the development and commercialization of products.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps after it partners with global pharma company for product development","og_description":"This Midcap Pharma stock which is engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services is up by 2.6 percent after the company collaborated with a global pharma major for the development and commercialization of products.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-11-25T07:22:58+00:00","article_modified_time":"2024-11-25T07:23:01+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/","name":"Pharma stock jumps after it partners with global pharma company for product development - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-11-25T07:22:58+00:00","dateModified":"2024-11-25T07:23:01+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"This Midcap Pharma stock which is engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services is up by 2.6 percent after the company collaborated with a global pharma major for the development and commercialization of products.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-partners-with-global-pharma-company-for-product-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps after it partners with global pharma company for product development"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/139514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=139514"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/139514\/revisions"}],"predecessor-version":[{"id":139517,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/139514\/revisions\/139517"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=139514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=139514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=139514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}